Michael LaValley
Profiles

Michael P. LaValley, PhD

Professor, Biostatistics - Boston University School of Public Health

617-358-2787
mlava@bu.edu
Crosstown Center - 336C
View Full Profile at BUMC

Biography

Michael LaValley, PhD. is a Professor of Biostatistics at the Boston University School of Public Health, where he teaches courses on meta-analysis, logistic regression, and survival analysis. Mike’s research efforts are focused on meta-analysis of study results, analysis of ordered categorical data, survival analysis, clinical trials, and outcome assessment in arthritis studies. He has also served as a Peace Corps Volunteer math and science teacher in Nepal in the late 1980s. He has a BA in Mathematics from American International College, a MA in Mathematics from Ohio State University, and a Ph.D. in Statistics from Penn State University. He joined the faculty at Boston University after completing a postdoctoral fellowship in Biostatistics at the Harvard School of Public Health.

Mike serves as the Research Director of the Boston University Core Center for Clinical Research, is a Member of the Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section (AMSC) for the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and as an Executive Committee Member for the Association of Rheumatology Professionals (ARP).

Other Positions

  • Member, Arthritis & Autoimmune Diseases Research Center - Boston University
  • - Boston Medical Center

Education

  • Pennsylvania State University, PhD Field of Study: Statistics
  • Ohio State University, MS Field of Study: Mathematics
  • American International College, BA Field of Study: Mathematics

Websites

Classes Taught

  • SPHBS820

Publications

  • Published on 6/17/2023

    Vakhshoorzadeh J, Lui JK, Sangani RA, Trojanowski MA, Bujor AM, LaValley MP, Klings ES. Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension. Respir Med. 2023 Sep; 216:107333. PMID: 37336329.

     Read At: PubMed
  • Published on 5/23/2023

    Lewis CL, Segal NA, Rabasa GV, LaValley MP, Williams GN, Nevitt MC, Lewis CE, Felson DT, Stefanik JJ. Hip Abductor Weakness and Its Association With New or Worsened Knee Pain: Data From the Multicenter Osteoarthritis Study. Arthritis Care Res (Hoboken). 2023 May 23. PMID: 37221156.

     Read At: PubMed
  • Published on 4/26/2023

    Liew JW, Rabasa G, LaValley M, Collins J, Stefanik J, Roemer FW, Guermazi A, Lewis CE, Nevitt M, Torner J, Felson D. Development of a Magnetic Resonance Imaging-Based Definition of Knee Osteoarthritis: Data From the Multicenter Osteoarthritis Study. Arthritis Rheumatol. 2023 Jul; 75(7):1132-1138. PMID: 36693143.

     Read At: PubMed
  • Published on 4/4/2023

    Girnis JL, Cavanaugh JT, Baker TC, Duncan RP, Fulford D, LaValley MP, Lawrence M, Nordahl T, Porciuncula F, Rawson KS, Saint-Hilaire M, Thomas CA, Zajac JA, Earhart GM, Ellis TD. Natural Walking Intensity in Persons With Parkinson Disease. J Neurol Phys Ther. 2023 Jul 01; 47(3):146-154. PMID: 37016469.

     Read At: PubMed
  • Published on 3/7/2023

    Rose MJ, Neogi T, Friscia B, Torabian KA, LaValley MP, Gheller M, Adamowicz L, Georgiev P, Viktrup L, Demanuele C, Wacnik PW, Kumar D. Reliability of Wearable Sensors for Assessing Gait and Chair Stand Function at Home in People With Knee Osteoarthritis. Arthritis Care Res (Hoboken). 2023 Sep; 75(9):1939-1948. PMID: 36734316.

     Read At: PubMed
  • Published on 1/30/2023

    Corrigan P, Felson DT, Lewis CL, Neogi T, LaValley MP, Gross KD, Nevitt MC, Lewis CE, Torner JC, Stefanik JJ. Relation of Temporal Asymmetry During Walking to Two-Year Knee Pain Outcomes in Those With Mild-to-Moderate Unilateral Knee Pain: An Exploratory Analysis From the Multicenter Osteoarthritis Study. Arthritis Care Res (Hoboken). 2023 Aug; 75(8):1735-1743. PMID: 36305013.

     Read At: PubMed
  • Published on 1/20/2023

    Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 20. PMID: 36662449.

     Read At: PubMed
  • Published on 1/18/2023

    Lui JK, Gillmeyer KR, Sangani RA, Smyth RJ, Gopal DM, Trojanowski MA, Bujor AM, Soylemez Wiener R, LaValley MP, Klings ES. A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis. Arthritis Care Res (Hoboken). 2023 Jul; 75(7):1462-1468. PMID: 35678779.

     Read At: PubMed
  • Published on 1/6/2023

    Lui JK, Sangani RA, Gillmeyer KR, Vakhshoorzadeh J, Trojanowski MA, Bujor AM, Gopal DM, Wiener RS, LaValley MP, Klings ES. Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovasc Drugs Ther. 2023 Jan 06. PMID: 36607535.

     Read At: PubMed
  • Published on 12/8/2022

    Quinn KA, Ahlman MA, Alessi HD, LaValley MP, Neogi T, Marko J, Novakovich E, Grayson PC. Association of 18 F-Fluorodeoxyglucose-Positron Emission Tomography Activity With Angiographic Progression of Disease in Large Vessel Vasculitis. Arthritis Rheumatol. 2023 Jan; 75(1):98-107. PMID: 35792044.

     Read At: PubMed

View 246 more publications:View Full Profile at BUMC

News & In the Media

View all profiles